This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AMN Healthcare Inks Deal to Address Healthcare System Needs
by Zacks Equity Research
This partnership is expected to boost AMN Healthcare's (AMN) Other Workforce Solutions segment.
Why AMN Healthcare (AMN) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Healthcare Stocks Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Earnings results of healthcare sector are likely to reflect solid demand for its products and services from aging population and the growing incidence of COVID-19 illness.
Zacks Market Edge Highlights: Microsoft, Walmart, Chevron, Teladoc Health and AMN Healthcare Services
by Zacks Equity Research
Zacks Market Edge Highlights: Microsoft, Walmart, Chevron, Teladoc Health and AMN Healthcare Services
5 Stocks to Navigate the Coronavirus Earnings Season
by Tracey Ryniec
This will be an earnings season unlike any other. Where should stock investors be looking for safety and deals?
Here's Why You Should Retain AMN Healthcare (AMN) for Now
by Zacks Equity Research
Investor confidence remains high on AMN Healthcare's (AMN) stock, thanks to solid prospects.
Teladoc (TDOC) Catches Eye: Stock Jumps 12.2%
by Zacks Equity Research
Teladoc (TDOC) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
AMN Healthcare (AMN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AMN Healthcare (AMN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is AMN Healthcare (AMN) Up 3.5% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Has AMN Healthcare Services (AMN) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (AMN) Outperforming Other Medical Stocks This Year?
Will AMN Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AMN Healthcare Services.
Teladoc (TDOC) Up 49% Year to Date: Will the Rally Continue?
by Zacks Equity Research
Teladoc (TDOC) benefits from its fast growing healthcare business and international expansion.
Company News for Feb 18, 2020
by Zacks Equity Research
Companies In The News Are: AYX, AMN, ANET, RBS
Will AMN Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AMN Healthcare Services.
AMN Healthcare (AMN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) Q4 results gain from core Nurse and Allied Solutions units.
Here's Why You Should Retain Integer Holdings Stock for Now
by Zacks Equity Research
Integer Holdings (ITGR) continues to benefit from portfolio management, strong foothold in the broader MedTech space and rising Non-Medical sales. However, intense competition remains a woe.
Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. HQY: Which Stock Is the Better Value Option?
AMN Healthcare (AMN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Nurse and Allied Solutions segment drives AMN Healthcare's (AMN) third-quarter results.
Earnings Preview: AMN Healthcare Services (AMN) Q3 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why AMN Healthcare (AMN) Could Beat Earnings Estimates Again
by Zacks Equity Research
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is AMN Healthcare (AMN) Up 5.6% Since Last Earnings Report?
by Zacks Equity Research
AMN Healthcare (AMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is AMN Healthcare Services (AMN) a Good Value Investor Pick?
by Zacks Equity Research
Let's see if AMN Healthcare Services (AMN) stock is a good choice for value-oriented investors right now from multiple angles.
Teladoc Up 33% Year to Date: Will the Momentum Continue?
by Zacks Equity Research
Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.